Health Catalyst, Inc - stock earnings

HCAT Quarterly earnings

DateEarningsRevenue
2023Q4 -30.3 million USD 75.1 million USD
2023Q3 -22.0 million USD 73.8 million USD
2023Q2 -32.6 million USD 73.2 million USD
2023Q1 -33.2 million USD 73.9 million USD
2022Q4 -35.8 million USD 69.2 million USD
2022Q3 -45.7 million USD 68.4 million USD
2022Q2 -33.4 million USD 70.6 million USD
2022Q1 -22.5 million USD 68.1 million USD
2021Q4 -49.0 million USD 64.7 million USD
2021Q3 -40.0 million USD 61.7 million USD
2021Q2 -35.8 million USD 59.6 million USD
2021Q1 -28.4 million USD 55.8 million USD
2020Q4 -43.0 million USD 53.3 million USD
2020Q3 -27.3 million USD 47.2 million USD
2020Q2 -27.2 million USD 43.3 million USD
2020Q1 -17.5 million USD 45.1 million USD
2019Q4 -14.3 million USD 43.5 million USD
2019Q3 -21.4 million USD 39.4 million USD
2019Q2 -10.7 million USD 36.8 million USD
2019Q1 -13.7 million USD 35.2 million USD
2018Q4 -13.6 million USD 36.1 million USD
2018Q3 -16.9 million USD 32.9 million USD
2018Q2 -19.3 million USD 23.0 million USD
2018Q1 -12.2 million USD 20.6 million USD

HCAT Yearly earnings

DateEarningsRevenue
2023 -118.1 million USD 295.9 million USD
2022 -137.4 million USD 276.2 million USD
2021 -153.2 million USD 241.9 million USD
2020 -115.0 million USD 188.8 million USD
2019 -60.1 million USD 154.9 million USD
2018 -62.0 million USD 112.6 million USD
2017 -47.0 million USD 73.1 million USD

HCAT

Price: $6.80

52 week price:
5.53
14.37

Earnings Per Share: -2.09 USD

P/E Ratio: -4.51

Exchange: NMS

Sector: Healthcare

Industry: Health Information Services

Volume: 258764

Market Capitalization: 385.3 million

Links: